Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at...

Area of Science:

• Neuroimmunology
• Central nervous system inflammatory diseases
• Cytokine signaling

Background:

• Multiple sclerosis (MS) is an inflammatory demyelinating disease involving immune cells and cytokines.
• Understanding early immunopathogenic processes is crucial for MS diagnosis and treatment.
• This study investigated potential signature cytokines in early MS.

Purpose of the Study:

• To identify specific cytokine profiles in patients with multiple sclerosis (MS) at the disease's onset.
• To differentiate early MS immunopathogenesis from other neurological conditions.
• To explore the relationship between cytokine levels and intrathecal IgG synthesis.

Main Methods:

• Serum and cerebrospinal fluid (CSF) samples were collected from 123 patients.
• Levels of key cytokines (IFN-γ, TNF-α, IL-4, IL-6, IL-10, IL-17, etc.) were measured.
• Cytokine ratios (e.g., Th1/Th2) and intrathecal IgG synthesis were analyzed.

Main Results:

• MS patients did not exhibit unique serum or CSF cytokine profiles compared to non-inflammatory neurological diseases (NIND) or symptomatic controls (SC).
• Inflammatory neurological disease (IND) patients showed significant Th1 cytokine polarization.
• Intrathecal IgG synthesis and its correlation with CSF IL-4 levels were higher in MS patients.

Conclusions:

• No specific signature cytokines were identified in early MS.
• Distinct Th1 polarization was observed in IND patients, not MS.
• Intrathecal IgG synthesis and CSF IL-4 correlation are key distinguishing factors for MS.